+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Inflammation Drug"

From
From
Aspirin Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Aspirin Market - Forecasts from 2022 to 2027

  • Report
  • August 2022
  • 140 Pages
  • Global
From
From
From
Toll-Like Receptor Modulators - Pipeline Insight, 2024 - Product Thumbnail Image

Toll-Like Receptor Modulators - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Toll-like receptor 9 (TLR-9) Modulator - Pipeline Insight, 2024 - Product Thumbnail Image

Toll-like receptor 9 (TLR-9) Modulator - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 100 Pages
  • Global
From
Toll-like-receptor-agonists - Pipeline Insight, 2024 - Product Thumbnail Image

Toll-like-receptor-agonists - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
From
Methyl Salicylate Market Report and Forecast 2023-2028 - Product Thumbnail Image

Methyl Salicylate Market Report and Forecast 2023-2028

  • Report
  • October 2023
  • 190 Pages
  • Global
From
From
Scleroderma Therapeutics Market Report and Forecast 2023-2031 - Product Thumbnail Image

Scleroderma Therapeutics Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 160 Pages
  • Global
From
From
Infliximab Drug Market - Global Forecast Report 2023-2031 - Product Thumbnail Image

Infliximab Drug Market - Global Forecast Report 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
From
From
From
Loading Indicator

The Immune Disorders Drugs market is composed of drugs used to treat a variety of conditions related to the immune system. These drugs are used to treat autoimmune diseases, allergies, and other conditions that affect the body's ability to fight off infection. Inflammation drugs are a subset of these drugs, used to reduce inflammation and swelling caused by an immune response. These drugs can be used to treat a variety of conditions, including rheumatoid arthritis, psoriasis, and Crohn's disease. They can also be used to reduce the risk of infection in patients with weakened immune systems. Inflammation drugs are typically administered orally or intravenously, and can be taken as a single dose or as part of a longer-term treatment plan. Common side effects of these drugs include nausea, vomiting, and diarrhea. Companies in the Immune Disorders Drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more